Researchers at the Keck School of Medicine of the University of Southern California (USC) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered high concentrations of a specific mutator protein in cells that develop resistance to drug treatment in chronic myeloid leukemia (CML).
Topic: Health News
Comments (0)
Comments
Add your comment
Please Login or Signup to leave a comment
